NCT05863975View on ClinicalTrials.gov

Treatment of HPV Infection in Perimenopausal and Postmenopausal Women

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
HPV Infection
Interventions
DRUG

Human interferon alpha 2b vaginal Effervescent capsules

①Interferon group: human interferon alpha 2b vaginal effervescent capsule vaginal medication. ② Promestriene group: promestriene cream vaginal medication. ③Interferon + promestriene combination group: two drugs were given in combination.

All Listed Sponsors
lead

Qianfoshan Hospital

OTHER